Blog
E2E Deal Insights Blog offers insights into everything related to buying, selling, integrating, and separating a company.
-

The Value of Exploring New Methods in M&A: Staying Critical Amid Innovation
M&A is evolving, with new technologies and methods reshaping traditional practices. From AI-driven analytics to ESG integration, innovation offers exciting opportunities – but staying critical is key to avoiding pitfalls. This article explores how companies can test and adopt new methods effectively while navigating the shifting landscape of corporate development. What strategies has your organization…
-

How to Create an Effective and High-Functioning Corporate Development Team?
Discover the essentials of creating a high-performing corporate development team, from defining objectives to measuring success. Learn how to structure your team, foster collaboration, and drive long-term value for your organization. Which of these insights resonates most with your experience?
-

Building a Healthcare Empire: The Acquisition Strategy of Novartis
Explore Novartis’ journey as a serial acquirer and its impact on the global healthcare landscape. From its acquisition strategies to post-merger integration and divestitures, learn how this pharmaceutical giant shapes its future. What’s your take on Novartis’ approach to innovation through M&A?
-

The Top 5 Private Equity Firms in Europe: Powerhouses Driving Growth and Innovation
Discover the top 5 private equity firms in Europe and how they’re driving growth and innovation across the continent. From sustainable investments to groundbreaking tech deals, these firms are shaping the future of Europe’s economy. What trends in private equity are you most excited about?
-

Serial Acquirers: A Deep Dive into Bristol-Myers Squibb
Bristol-Myers Squibb has redefined growth through strategic acquisitions, with highlights like its $74 billion Celgene deal. This article delves into the company’s acquisition history, methods, and integration strategies, offering insights into its future in the biopharmaceutical industry. Do you think BMS’s focus on oncology and immunology is the right path for sustained growth?
-

Contingent Value Rights Explained: Balancing Risk and Reward in Transactions
Contingent Value Rights (CVRs) are innovative financial tools that bridge valuation gaps and mitigate risks in M&A deals. Learn how CVRs work, when they are used, and their impact on real-world transactions. Have you seen CVRs in action?
-

The 10 Biggest and Most Prestigious M&A Award Shows in the World
Discover the top 10 M&A award shows that celebrate excellence in global business. From the Americas to Asia, these events highlight groundbreaking deals and visionary leaders shaping industries. Which award show do you think sets the gold standard in M&A?
-

Navigating Change: The Importance of Tracking PMI and Synergy Innovations
Post-merger integration and synergy capture are critical to the success of M&A deals. Staying updated on the latest trends and tools can mean the difference between success and failure. Learn how to stay ahead, avoid common pitfalls, and explore innovations transforming the field. What strategies do you use to stay informed?
-

How Rolling Equity Impacts Deal Financing and Seller Strategy
Rolling equity is a key concept in M&A, allowing sellers to retain a stake in the company post-sale. But what are the benefits and risks? Discover why rolling equity might be the right fit for your next deal. Have you used rolling equity in a deal? What’s your perspective on its pros and cons?
-

The Top 5 Venture Capital Firms in Asia: Driving Innovation Across the Continent
Asia’s startup ecosystem is booming, and venture capital is at its heart. Discover the top 5 VC firms driving this transformation and explore the future of innovation in the region. Which sectors do you think will define the next wave of Asian startups?
-

Achieving Seamless Integration with Effective Clean Teams
Learn how clean teams can make post-merger integration smoother and more successful. This article covers their role, setup, benefits, and pitfalls—plus tips to maximize their effectiveness. Have you worked with a clean team in an M&A process? What advice would you give others?
-

How AT&T’s Serial Acquisitions Are Reshaping the Telecom and Media Landscape
AT&T’s acquisition strategy has shaped its evolution into a major telecommunications and media player. From the landmark Time Warner deal to its recent acquisitions, AT&T has made moves that align with its long-term vision. What do you think AT&T’s future acquisitions will look like?
